Evaluation and initial management of acute kidney injury

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue 4, 2008, Pages 962-967

  Himmelfarb, Jonathan ^a   Joannidis, Michael ^b   Molitoris, Bruce ^c   Schietz, Miet ^d   Okusa, Mark D ^e   Warnock, David ^f   Laghi, Franco ^g   Goldstein, Stuart L ^h   Prielipp, Richard ⁱ   Parikh, Chirag R ^j   Pannu, Neesh ^k   Lobo, Suzana M ^l   Shah, Sudhir ^m   D'Intini, Vincent ⁿ   Kellum, John A ^o  

^a MAINE MEDICAL CENTER   (United States)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e UNIVERSITY OF VIRGINIA   (United States)

^f UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^g LOYOLA UNIVERSITY CHICAGO   (United States)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

ⁱ MAYO CLINIC   (United States)

^j YALE UNIVERSITY   (United States)

^k UNIVERSITY OF ALBERTA   (Canada)

^l São José do Rio Preto Medicine School   (Brazil)

^m UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

ⁿ GEELONG HOSPITAL   (Australia)

^o UNIVERSITY OF PITTSBURGH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ACUTE DISEASE; ARTICLE; BLOOD VOLUME; CLASSIFICATION; COMORBIDITY; CONSENSUS DEVELOPMENT; DELPHI STUDY; DISEASE COURSE; FLUID THERAPY; GLOMERULUS FILTRATION RATE; HOSPITALIZATION; HUMAN; KIDNEY CIRCULATION; KIDNEY DISEASE; MEDICAL RESEARCH; METABOLISM; NOMENCLATURE; ORGANIZATION AND MANAGEMENT; PATHOPHYSIOLOGY; PROGRAM DEVELOPMENT; RENAL REPLACEMENT THERAPY; RISK FACTOR;

ACUTE DISEASE; BIOLOGICAL MARKERS; BIOMEDICAL RESEARCH; BLOOD VOLUME; COMORBIDITY; CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; DELPHI TECHNIQUE; DISEASE PROGRESSION; FLUID THERAPY; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; PROGRAM DEVELOPMENT; RENAL CIRCULATION; RENAL REPLACEMENT THERAPY; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TERMINOLOGY AS TOPIC;

EID: 49149104181     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04971107     Document Type: Article

References (51)

1. Thadhani R, Pascual M, Bonventre JV: Acute renal failure. N Engl J Med 334: 1448-1460, 1996
2. Schrier RW, Wang W, Poole B, Mitra A: Acute renal failure: Definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 114: 5-14, 2004
3. Fry AC, Farrington K: Management of acute renal failure. Postgrad Med J 82: 106-116, 2006
4. Lameire N, Van BW, Vanholder R: Acute renal failure. Lancet 365: 417-430, 2005
5. Gottlieb RH, Weinberg EP, Rubens DJ, Monk RD, Grossman EB: Renal sonography: Can it be used more selectively in the setting of an elevated serum creatinine level? Am J Kidney Dis 29: 362-367, 1997
6. Keyserling HF, Fielding JR, Mittelstaedt CA: Renal sonography in the intensive care unit: When is it necessary? J Ultrasound Med 21: 517-520, 2002
7. Badr KF, Ichikawa I: Prerenal failure: A deleterious shift from renal compensation to decompensation. N Engl J Med 319: 623-629, 1988
8. Venkataraman R, Kellum JA: Prevention of acute renal failure. Chest 131: 300-308, 2007
9. Bellomo R, Bonventre J, Macias W, Pinsky M: Management of early acute renal failure: Focus on post-injury prevention. Curr Opin Crit Care 11: 542-547, 2005
10. Albanese J, Leone M, Delmas A, Martin C: Terlipressin or norepinephrine in hyperdynamic septic shock: A prospective, randomized study. Crit Care Med 33: 1897-1902, 2005
11. Redl-Wenzl EM, Armbruster C, Edelmann G, Fischl E, Kolacny M, Wechsler-Fördös A, Sporn P: The effects of norepinephrine on hemodynamics and renal function in severe septic shock states. Intensive Care Med 19: 151-154, 1993
12. Denton MD, Chertow GM, Brady HR: 'Renal-dose' dopamine for the treatment of acute renal failure: Scientific rationale, experimental studies and clinical trials. Kidney Int 50: 4-14, 1996
13. Friedrich JO, Adhikari N, Herridge MS, Beyene J: Meta-analysis: Low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 142: 510-524, 2005
14. Lauschke A, Teichgraber UK, Frei U, Eckardt KU: 'Low-dose' dopamine worsens renal perfusion in patients with acute renal failure. Kidney Int 69: 1669-1674, 2006
15. Tumlin JA, Wang A, Murray PT, Mathur VS: Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: A pilot trial in the prevention of contrast nephropathy. Am Heart J 143: 894-903, 2002
16. Chu VL, Cheng JW: Fenoldopam in the prevention of contrast media-induced acute renal failure. Ann Pharmacother 35: 1278-1282, 2001
17. Brienza N, Malcangi V, Dalfino L, Trerotoli P, Guagliardi C, Bortone D, Faconda G, Ribezzi M, Ancona G, Bruno F, Fiore T: A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients. Crit Care Med 34: 707-714, 2006
18. Morelli A, Ricci Z, Bellomo R, Ronco C, Rocco M, Conti G, De GA, Picchini U, Orecchioni A, Portieri M, Coluzzi F, Porzi P, Serio P, Bruno A, Pietropaoli P: Prophylactic fenoldopam for renal protection in sepsis: A randomized, double-blind, placebo-controlled pilot trial. Crit Care Med 33: 2451-2456, 2005
19. Tumlin JA, Finkel KW, Murray PT, Samuels J, Cotsonis G, Shaw AD: Fenoldopam mesylate in early acute tubular necrosis: A randomized, double-blind, placebo-controlled clinical trial. Am J Kidney Dis 46: 26-34, 2005
20. Stone GW, McCullough PA, Tumlin JA, Lepor NE, Madyoon H, Murray P, Wang A, Chu AA, Schaer GL, Stevens M, Wilensky RL, O'Neill WW: Fenoldopam mesylate for the prevention of contrast-induced nephropathy: A randomized controlled trial. JAMA 290: 2284-2291, 2003
21. Sward K, Valsson F, Odencrants P, Samuelsson O, Ricksten SE: Recombinant human atrial natriuretic peptide in ischemic acute renal failure: A randomized placebo-controlled trial. Crit Care Med 32: 1310-1315, 2004
22. Akamatsu N, Sugawara Y, Tamura S, Kaneko J, Togashi J, Kishi Y, Imamura H, Kokudo N, Makuuchi M: Prevention of renal impairment by continuous infusion of human atrial natriuretic peptide after liver transplantation. Transplantation 80: 1093-1098, 2005
23. Sato K, Sekiguchi S, Kawagishi N, Akamatsu Y, Enomoto Y, Takeda I, Fukushima D, Fujimori K, Sato A, Satomi S: Continuous low-dose human atrial natriuretic peptide promotes diuresis in oliguric patients after living donor liver transplantation. Transplant Proc 38: 3591-3593, 2006
24. Allgren RL, Marbury TC, Rahman SN, Weisberg LS, Fenves AZ, Lafayette RA, Sweet RM, Genter FC, Kurnik BR, Conger JD, Sayegh MH: Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med 336: 828-834, 1997
25. Lewis J, Salem MM, Chertow GM, Weisberg LS, McGrew F, Marbury TC, Allgren RL: Atrial natriuretic factor in oliguric acute renal failure: Anaritide Acute Renal Failure Study Group. Am J Kidney Dis 36: 767-774, 2000
26. Ix JH, McCulloch CE, Chertow GM: Theophylline for the prevention of radiocontrast nephropathy: A meta-analysis. Nephrol Dial Transplant 19: 2747-2753, 2004
27. Bagshaw SM, Ghali WA: Theophylline for prevention of contrast-induced nephropathy: A systematic review and meta-analysis. Arch Intern Med 165: 1087-1093, 2005
28. Benoehr P, Krueth P, Bokemeyer C, Grenz A, Osswald H, Hartmann JT: Nephroprotection by theophylline in patients with cisplatin chemotherapy: A randomized, single-blinded, placebo-controlled trial. J Am Soc Nephrol 16: 452-458, 2005
29. Givertz MM, Massie BM, Fields TK, Pearson LL, Dittrich HC: The effects of KW-3902, an adenosine A1-receptor antagonist, on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance. J Am Coll Cardiol 50: 1551-1560, 2007
30. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C: Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA 294: 813-818, 2005
31. Mehta RL, Pascual MT, Soroko S, Chertow GM: Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA 288: 2547-2553, 2002
32. Solomon R, Werner C, Mann D, D'Elia JA, Silva P: Effects of saline, mannitol and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331: 1416-1420, 1994
33. Rosner MH, Okusa MD: Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol 1: 19-31, 2006
34. Brezis M, Agmon Y, Epstein FH: Determinants of intrarenal oxygenation: I. Effects of diuretics. Am J Physiol 267: F1059-F1062, 1994
35. Ho KM, Sheridan DJ: Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ 333: 420, 2006
36. Tepel M, van der GM, Schwarzfeld C, Laufer U, Liermann D, Zidek W: Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343: 180-184, 2000
37. Marenzi G, Assanelli E, Marana I, Lauri G, Campodonico J, Grazi M, De MM, Galli S, Fabbiocchi F, Montorsi P, Veglia. F, Bartorelli AL: N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 354: 2773-2782, 2006
38. Bagshaw SM, McAlister FA, Manns BJ, Ghali WA: Acetylcysteine in the prevention of contrast-induced nephropathy: A case study of the pitfalls in the evolution of evidence. Arch Intern Med 166: 161-166, 2006
39. Hynninen MS, Niemi TT, Poyhia R, Raininko EI, Salmenpera MT, Lepantalo MJ, Railo MJ, Tallgren MK: N-acetylcysteine for the prevention of kidney injury in abdominal aortic surgery: A randomized, double-blind, placebo-controlled trial. Anesth Analg 102: 1638-1645, 2006
40. Macedo E, Abdulkader R, Castro I, Sobrinho AC, Yu L, Vieira JM, Jr: Lack of protection of N-acetylcysteine (NAC) in acute renal failure related to elective aortic aneurysm repair: A randomized controlled trial. Nephrol Dial Transplant 21: 1863-1869, 2006
41. Komisarof JA, Gilkey GM, Peters DM, Koudelka CW, Meyer MM, Smith SM: N-acetylcysteine for patients with prolonged hypotension as prophylaxis for acute renal failure (NEPHRON). Crit Care Med 35: 435-441, 2007
42. Brown CV, Rhee P, Chan L, Evans K, Demetriades D, Velmahos GC: Preventing renal failure in patients with rhabdomyolysis: Do bicarbonate and mannitol make a difference? J Trauma 56: 1191-1196, 2004
43. Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, Bersin RM, Van MA, Simonton CA, III, Rittase RA, Norton HJ, Kennedy TP: Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 291: 2328-2334, 2004
44. Briguori C, Airoldi F, D'Andrea D, Bonizzoni E, Morici N, Focaccio A, Michev I, Montorfano M, Carlino M, Cosgrave J, Ricciardelli B, Colombo A: Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): A randomized comparison of 3 preventive strategies. Circulation 115: 1211-1217, 2007
45. Ozcan EE, Guneri S, Akdeniz B, Akyildiz IZ, Senaslan O, Baris N, Aslan O, Badak O: Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy: A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial. Am Heart J 154: 539-544, 2007
46. Pinsky MR, Teboul JL: Assessment of indices of preload and volume responsiveness. Curr Opin Crit Care 11: 235-239, 2005
47. Levy MM, Macias WL, Vincent JL, Russell JA, Siltva E, Trzaskoma B, Williams MD: Early changes in organ function predict eventual survival in severe sepsis. Crit Care Med 33: 2194-2201, 2005
48. Rivers EP: Fluid-management strategies in acute lung injury: Liberal, conservative, or both? N Engl J Med 354: 2598-2600, 2006
49. Espinel CH: The FENa test: Use in the differential diagnosis of acute renal failure. JAMA 236: 579-581, 1976
50. Steiner RW: Interpreting the fractional excretion of sodium. Am J Med 77: 699-702, 1984
51. Carvounis CP, Nisar S, Guro-Razuman S: Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure. Kidney Int 62: 2223-2229, 2002